BUPRENORPHINE 10 MCG/HR PATCH

buprenorphine
$30.1705per EA
DEA Schedule CIII

Strength

10 ug/h

Manufacturer

Alvogen Inc.

NDC

47781040704

Classification

Generic

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Last Updated

2/18/2026

Active Ingredients

BUPRENORPHINE

Approval Type

Generic (ANDA)

FDA Application

ANDA207490

On Market Since

5/17/2022

Pharmacological Classes

Partial Opioid Agonist
Partial Opioid Agonists

Price History

1W

0.0%

1M

0.0%

3M

-5.9%

6M

-14.6%

1Y

-6.0%

3Y

-26.2%

5Y

N/A

All

-36.0%